In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that ...

The biotech, which earlier this year laid off nearly all of its staff, also announced a PIPE that will hand it $175 million in new funding.

Such detection speed is the result of combining ML and UV absorbance spectroscopy to detect microbial contamination in cell therapy products.

For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...

The city turned over nearly 4,500 records from Chris Bausch’s personal devices in response to The Tribune’s lawsuit.

The Commission on enforced disappearance has said they found specialised interrogation rooms equipped with "torture devices" ...

Investing.com -- Vor Biopharma Inc (NASDAQ: VOR) stock surged 85% after the company announced an exclusive licensing agreement with China’s RemeGen Co., Ltd. for telitacicept, a novel dual-target ...

Everybody can do their part and not buy or order dishes with conch, locally known as lambi. The molusk needs the time from 1 July to 31 October to breed so that the species still continues to be ...